Sciensus - Rare Disease Services

Sciensus is a life sciences business specialising in patient access, engagement and insight solutions. Our team has extensive experience in the rare and orphan disease market, and is committed to getting rare medicines to hard-to-reach patients in Europe and beyond. For over 30 years, we’ve delivered on every aspect of this vital transaction; from early access all the way to full commercialization, including patient support programs. With extensive experience behind us, we’re not daunted by the complexities of language, red tape or local rules and regulations. Instead, we work day and night to get your life-changing medicine to every patient, everywhere. Our team has extensive experience in the rare and orphan disease market, including: - The ability to quickly scale your business outside the US. - Local regulatory expertise to keep you and your product safe and compliant through strong central governance on patient activities, PV, PQC. - An established network of existing customers, across 28 markets in Europe, within hospital, pharmacy, clinics and wholesalers. - In-depth knowledge for identifying the patients who are waiting for life saving drugs. - Highly adaptable Patient Support Programme to ensure we’re supporting patients that are on your medication, across all European countries. Over the last 12 months alone, we’ve bought and sold over €350 million of orphan drugs and helped 10,000 patients. Learn more at: https://www.sciensus.com/rare/